Abstract:Previously we showed that supplementing a high fat diet (HFD) with a freeze-dried powder of 24 commonly consumed fruits and vegetables (F&V) prevented HFD-induced non-alcoholic fatty liver disease (NAFLD). Since the experimental diets were isocaloric with major difference being in their antioxidant content, we hypothesized that the observed effects of F&V maybe due to their antioxidant property resulting in reduced formation of inflammatory cytokines and lipids such as TNF-α and sphingolipid ceramides. Both TNF-α and ceramides have been implicated as risk factors for NFALD. The objective of this study was to test the above hypothesis. Six-wk-old male C57BL/6 J mice were randomized to three groups (12/group) to receive one of the following diets: low fat (LF, 10% kcal fat), high fat (HF, 45% kcal fat), and HF plus 15% freeze-dried mixture of F&V (HF + F&V). After 20 weeks, mice were euthanized, blood and liver samples were collected for analyses of cytokines, lipids, and malondialdehyde (MDA), a lipid peroxidation biomarker, and pathways involved in ceramide formation. Mice fed the HF diet had significantly higher liver steatosis and plasma and/or liver ceramides, TNF-α, and MDA compared to those fed the LF diet. However, F&V supplementation prevented HF diet-induced NAFLD and significantly reduced upregulated TNF-α, ceramide, and MDA levels. Because of key role of ceramides in NFALD development, we further determined the mechanism of F&V-induced decrease in ceramide formation focusing on de novo synthesis and activity of sphingomyelinase (SMase), the enzyme that hydrolyzes sphingomyelin to generate ceramide and is modulated by oxidative stress. There was no difference in de novo ceramide synthesis; however, F&V supplementation significantly prevented HF-induced higher SMase activity. Further, liver MDA levels were positively correlated with levels of ceramides, TNF-α, SMase activity, and liver steatosis area. The results from this study suggest that prevention of NFALD by F&V might be mediated through reduction in oxidative stress, consequently suppressing production of pro-inflammatory cytokines, and inhibiting SMase activity that leads to reduction of ceramide levels. This study was supported by the U.S. Department of Agriculture – Agricultural Research Service (ARS), under Agreement No. 58-1950-4-003.

Caffeic Acid Prevents Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet Through Gut Microbiota Modulation in Mice.

Caffeic Acid Reduces Body Weight by Regulating Gut Microbiota in Diet-Induced-obese Mice

Allyl Isothiocyanate Ameliorates Lipid Accumulation and Inflammation in Nonalcoholic Fatty Liver Disease Via the Sirt1/AMPK and NF-κB Signaling Pathways.

Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1

The Protective Effects of Cinnamyl Alcohol Against Hepatic Steatosis, Oxidative and Inflammatory Stress in Nonalcoholic Fatty Liver Disease Induced by Childhood Obesity

Caffeic Acid Supplement Alleviates Colonic Inflammation and Oxidative Stress Potentially Through Improved Gut Microbiota Community in Mice

Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids

Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic fatty liver disease by inhibiting bacterial bile salt hydrolase activity

N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function

(-)-Hydroxycitric Acid Alleviates Oleic Acid-Induced Steatosis, Oxidative Stress, and Inflammation in Primary Chicken Hepatocytes by Regulating AMP-Activated Protein Kinase-Mediated Reactive Oxygen Species Levels

P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP-activated protein kinase/CREB regulated transcription coactivator 2 pathway

Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis

Caffeic Acid Ameliorates Colitis in Association with Increased Akkermansia Population in the Gut Microbiota of Mice.

Carnosic Acid Suppressed the Formation of NETs in Alcoholic Hepatosteatosis Based on P2X7R-NLRP3 Axis.

Cichoric Acid Prevents Free Fatty Acids Induced Lipid Metabolism Disorders via Regulating Bmal1 in HepG2 Cells.

Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation

Prevention of Non-Alcoholic Fatty Liver Disease by Fruits and Vegetables Supplementation in Mice is Associated with Their Antioxidant Property

A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease

Tauroursodeoxycholic Acid Inhibits Intestinal Inflammation and Barrier Disruption in Mice with Non-Alcoholic Fatty Liver Disease.

Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways.

The Protective Effect and Mechanism of the FXR Agonist Obeticholic Acid Via Targeting Gut Microbiota in Non-Alcoholic Fatty Liver Disease.